Published in Eukaryot Cell on November 02, 2012
Regulation and biological function of a flagellar glucose transporter in Leishmania mexicana: a potential glucose sensor. FASEB J (2014) 0.91
Dissecting Leishmania infantum Energy Metabolism - A Systems Perspective. PLoS One (2015) 0.76
Evidence for loss of a partial flagellar glycolytic pathway during trypanosomatid evolution. PLoS One (2014) 0.75
Trypanosoma evansi is alike to Trypanosoma brucei brucei in the subcellular localisation of glycolytic enzymes. Mem Inst Oswaldo Cruz (2015) 0.75
Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat Genet (2007) 4.58
Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2. Proc Natl Acad Sci U S A (1997) 2.53
Localization of nine glycolytic enzymes in a microbody-like organelle in Trypanosoma brucei: the glycosome. FEBS Lett (1977) 2.44
Compartmentation of carbohydrate metabolism in trypanosomes. Annu Rev Microbiol (1987) 2.34
The diverse functions of GAPDH: views from different subcellular compartments. Cell Signal (2010) 2.15
Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania. Genome Res (2011) 1.90
Retooling Leishmania metabolism: from sand fly gut to human macrophage. FASEB J (2007) 1.85
Metabolic functions of glycosomes in trypanosomatids. Biochim Biophys Acta (2006) 1.80
Genetic characterization of glucose transporter function in Leishmania mexicana. Proc Natl Acad Sci U S A (2003) 1.64
Experimental and in silico analyses of glycolytic flux control in bloodstream form Trypanosoma brucei. J Biol Chem (2005) 1.60
Evolution of parasitism: kinetoplastid protozoan history reconstructed from mitochondrial rRNA gene sequences. Proc Natl Acad Sci U S A (1988) 1.48
Novel roles for GAPDH in cell death and carcinogenesis. Cell Death Differ (2009) 1.47
Glycolysis as a target for the design of new anti-trypanosome drugs. Drug Resist Updat (2001) 1.45
Proline metabolism in procyclic Trypanosoma brucei is down-regulated in the presence of glucose. J Biol Chem (2005) 1.44
Two tandemly linked identical genes code for the glycosomal glyceraldehyde-phosphate dehydrogenase in Trypanosoma brucei. EMBO J (1986) 1.42
Comparison of the A2 gene locus in Leishmania donovani and Leishmania major and its control over cutaneous infection. J Biol Chem (2003) 1.42
Differentiation of Leishmania donovani in host-free system: analysis of signal perception and response. Mol Biochem Parasitol (2005) 1.35
Virulence of Leishmania major in macrophages and mice requires the gluconeogenic enzyme fructose-1,6-bisphosphatase. Proc Natl Acad Sci U S A (2006) 1.34
Evidence that intracellular beta1-2 mannan is a virulence factor in Leishmania parasites. J Biol Chem (2003) 1.34
Evolution of energy metabolism and its compartmentation in Kinetoplastida. Kinetoplastid Biol Dis (2003) 1.33
Glycosomes: parasites and the divergence of peroxisomal purpose. Mol Microbiol (2004) 1.29
Autonomous replication of bacterial DNA plasmid oligomers in Leishmania. Mol Biochem Parasitol (1994) 1.28
Genome sequencing of the lizard parasite Leishmania tarentolae reveals loss of genes associated to the intracellular stage of human pathogenic species. Nucleic Acids Res (2011) 1.23
Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection. Mol Microbiol (2001) 1.21
Metabolic aspects of glycosomes in trypanosomatidae - new data and views. Parasitol Today (2000) 1.18
The expression of biologically active human p53 in Leishmania cells: a novel eukaryotic system to produce recombinant proteins. Nucleic Acids Res (1995) 1.15
Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase. Proc Natl Acad Sci U S A (1999) 1.12
Compartmentation of phosphoglycerate kinase in Trypanosoma brucei plays a critical role in parasite energy metabolism. Proc Natl Acad Sci U S A (1998) 1.11
Isotopomer profiling of Leishmania mexicana promastigotes reveals important roles for succinate fermentation and aspartate uptake in tricarboxylic acid cycle (TCA) anaplerosis, glutamate synthesis, and growth. J Biol Chem (2011) 1.09
The cytosolic and glycosomal isoenzymes of glyceraldehyde-3-phosphate dehydrogenase in Trypanosoma brucei have a distant evolutionary relationship. Eur J Biochem (1991) 1.09
When, how and why glycolysis became compartmentalised in the Kinetoplastea. A new look at an ancient organelle. Int J Parasitol (2011) 1.08
Crystal structure of glycosomal glyceraldehyde-3-phosphate dehydrogenase from Leishmania mexicana: implications for structure-based drug design and a new position for the inorganic phosphate binding site. Biochemistry (1995) 1.06
Pentose phosphate metabolism in Leishmania mexicana. Mol Biochem Parasitol (2003) 1.01
Phenotypic characterization of a glucose transporter null mutant in Leishmania mexicana. Mol Biochem Parasitol (2007) 1.01
Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase: structure, catalytic mechanism and targeted inhibitor design. FEBS Lett (1998) 1.00
Metabolic changes in glucose transporter-deficient Leishmania mexicana and parasite virulence. J Biol Chem (2006) 0.97
Evidence that intracellular stages of Leishmania major utilize amino sugars as a major carbon source. PLoS Pathog (2010) 0.97
Screening Leishmania donovani-specific genes required for visceral infection. Mol Microbiol (2010) 0.96
Subcellular compartmentation of glycolytic intermediates in Trypanosoma brucei. Eur J Biochem (1981) 0.94
The cytosolic and glycosomal glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma brucei. Kinetic properties and comparison with homologous enzymes. Eur J Biochem (1991) 0.94
Glyceraldehyde-phosphate dehydrogenase from Trypanosoma brucei. Comparison of the glycosomal and cytosolic isoenzymes. Eur J Biochem (1987) 0.93
Conformational changes in Leishmania mexicana glyceraldehyde-3-phosphate dehydrogenase induced by designed inhibitors. J Mol Biol (2001) 0.93
Molecular analysis of the cytosolic and glycosomal glyceraldehyde-3-phosphate dehydrogenase in Leishmania mexicana. Mol Biochem Parasitol (1992) 0.90
Channel-forming activities in the glycosomal fraction from the bloodstream form of Trypanosoma brucei. PLoS One (2012) 0.89
Molecular analysis of glyceraldehyde-3-phosphate dehydrogenase in Trypanoplasma borelli: an evolutionary scenario of subcellular compartmentation in kinetoplastida. J Mol Evol (1995) 0.89
A genomic-based approach combining in vivo selection in mice to identify a novel virulence gene in Leishmania. PLoS Negl Trop Dis (2008) 0.86
Identification and characterization of a novel Ribose 5-phosphate isomerase B from Leishmania donovani. Biochem Biophys Res Commun (2012) 0.83
Refined 3.2 A structure of glycosomal holo glyceraldehyde phosphate dehydrogenase from Trypanosoma brucei brucei. Acta Crystallogr D Biol Crystallogr (1995) 0.83
Delayed in vitro utilization of glucose by Leishmania tropica promastigotes. J Protozool (1974) 0.82
Structure, function, and biogenesis of glycosomes in kinetoplastida. J Bioenerg Biomembr (1994) 0.82
Expression of a Leishmaniadonovani nucleotide sugar transporter in Leishmaniamajor enhances survival in visceral organs. Exp Parasitol (2011) 0.82
The rational design of trypanocidal drugs: selective inhibition of the glyceraldehyde-3-phosphate dehydrogenase in Trypanosomatidae. Ann Trop Med Parasitol (1995) 0.81
Regulation and adaptation of glucose metabolism of the parasitic protist Leishmania donovani at the enzyme and mRNA levels. J Bacteriol (1999) 0.80
Regulation of human p53 activity and cell localization by alternative splicing. Mol Cell Biol (2004) 2.01
Comparison of the A2 gene locus in Leishmania donovani and Leishmania major and its control over cutaneous infection. J Biol Chem (2003) 1.42
Determinants for the development of visceral leishmaniasis disease. PLoS Pathog (2013) 1.22
Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection. Infect Immun (2003) 1.20
Control of alpha subunit of eukaryotic translation initiation factor 2 (eIF2 alpha) phosphorylation by the human papillomavirus type 18 E6 oncoprotein: implications for eIF2 alpha-dependent gene expression and cell death. Mol Cell Biol (2004) 1.18
Immunization with a Toll-like receptor 7 and/or 8 agonist vaccine adjuvant increases protective immunity against Leishmania major in BALB/c mice. Infect Immun (2008) 1.13
Human papillomavirus type 33 polymorphisms and high-grade squamous intraepithelial lesions of the uterine cervix. J Infect Dis (2006) 1.07
Development of a genetic assay to distinguish between Leishmania viannia species on the basis of isoenzyme differences. Clin Infect Dis (2006) 1.06
Comparison of the effects of Leishmania major or Leishmania donovani infection on macrophage gene expression. Infect Immun (2007) 1.04
Diagnosis of American visceral leishmaniasis in humans and dogs using the recombinant Leishmania donovani A2 antigen. Diagn Microbiol Infect Dis (2002) 1.03
First-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimony. PLoS Negl Trop Dis (2009) 1.01
Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis. Clin Infect Dis (2007) 1.00
Intracellular eukaryotic parasites have a distinct unfolded protein response. PLoS One (2011) 0.98
Reducing visceral leishmaniasis by insecticide impregnation of bed-nets, Bangladesh. Emerg Infect Dis (2013) 0.97
Screening Leishmania donovani-specific genes required for visceral infection. Mol Microbiol (2010) 0.96
Adjuvants for Leishmania vaccines: from models to clinical application. Front Immunol (2012) 0.92
Analysis of the PDZ binding specificities of Influenza A virus NS1 proteins. Virol J (2011) 0.91
Localization and induction of the A2 virulence factor in Leishmania: evidence that A2 is a stress response protein. Mol Microbiol (2010) 0.91
A FRET-based real-time PCR assay to identify the main causal agents of New World tegumentary leishmaniasis. PLoS Negl Trop Dis (2013) 0.91
Involvement of the Leishmania donovani virulence factor A2 in protection against heat and oxidative stress. Exp Parasitol (2012) 0.90
Leishmania donovani zymodeme MON-37 isolated from an autochthonous visceral leishmaniasis patient in Sri Lanka. Pathog Glob Health (2012) 0.89
Identification and characterization of a protein-tyrosine phosphatase in Leishmania: Involvement in virulence. J Biol Chem (2006) 0.89
The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia. Cancer Detect Prev (2005) 0.89
Ubiquitination and proteasome degradation of the E6 proteins of human papillomavirus types 11 and 18. J Gen Virol (2004) 0.89
CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani. MBio (2015) 0.88
Involvement of nuclear export in human papillomavirus type 18 E6-mediated ubiquitination and degradation of p53. J Virol (2005) 0.88
Leishmanization revisited: immunization with a naturally attenuated cutaneous Leishmania donovani isolate from Sri Lanka protects against visceral leishmaniasis. Vaccine (2012) 0.88
A genomic-based approach combining in vivo selection in mice to identify a novel virulence gene in Leishmania. PLoS Negl Trop Dis (2008) 0.86
Cross-sectional study to assess risk factors for leishmaniasis in an endemic region in Sri Lanka. Am J Trop Med Hyg (2013) 0.85
Generation and evaluation of A2-expressing Lactococcus lactis live vaccines against Leishmania donovani in BALB/c mice. J Med Microbiol (2011) 0.84
In vivo selection for Leishmania donovani miniexon genes that increase virulence in Leishmania major. Mol Microbiol (2004) 0.83
Heterologous expression of a mammalian protein tyrosine phosphatase gene in Leishmania: effect on differentiation. Mol Microbiol (2003) 0.83
Expression of a Leishmaniadonovani nucleotide sugar transporter in Leishmaniamajor enhances survival in visceral organs. Exp Parasitol (2011) 0.82
Detection of iNOS gene expression in cutaneous leishmaniasis biopsy tissue. Mol Biochem Parasitol (2002) 0.80
Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix. Int J Cancer (2007) 0.80
Comparison of p53 and the PDZ domain containing protein MAGI-3 regulation by the E6 protein from high-risk human papillomaviruses. Virol J (2008) 0.79
Deletion of an ATP-binding cassette protein subfamily C transporter in Leishmania donovani results in increased virulence. Mol Biochem Parasitol (2012) 0.77
Mass Spectrometry-Based Visualization of Molecules Associated with Human Habitats. Anal Chem (2016) 0.77
A2 and other visceralizing proteins of Leishmania: role in pathogenesis and application for vaccine development. Subcell Biochem (2014) 0.76
Screening Leishmania donovani complex-specific genes required for visceral disease. Methods Mol Biol (2015) 0.76
Adaptation of Leishmania donovani to cutaneous and visceral environments: in vivo selection and proteomic analysis. J Proteome Res (2015) 0.75
Optimized CRISPR-Cas9 Genome Editing for Leishmania and Its Use To Target a Multigene Family, Induce Chromosomal Translocation, and Study DNA Break Repair Mechanisms. mSphere (2017) 0.75